Home › Researcher directory › Farah Choulli
Farah Choulli
Affiliation : Cadi Ayyad University · Centre Hospitalier Universitaire Mohammed VI
- 16Publications (affiliation in Morocco)
- 16Total publications
- 25Citations
- 3h-index
Research profile
Farah Choulli has 16 indexed publications (2023–2026). Their work appears mainly in “Journal of Clinical Oncology”, “Annals of Oncology” and “ESMO Open”. Their most cited article, “Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descripti” (2024), has been cited 12 times. 11 of these publications date from the last three years of activity. Their work is co-authored with at least 12 researchers.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsResearch areas
- Lung Cancer Diagnosis and Treatment
- Breast Cancer Treatment Studies
- Lung Cancer Research Studies
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
Publications (16)
- 567eP A clinically driven AI model for optimal treatment sequencing in non-small cell lung cancer (NSCLC): Moroccan cohort
- Adjuvant (Ad) and neoadjuvant (NAd) strategies in higher risk hormone receptor–positive (HR+)/HER2-negative (HER2−) early breast cancer (EBC): Moroccan real-world outcomes.
- Second-line chemotherapy rechallenge in lung cancer patients: a Moroccan real-world study
- 417P: Deep neural networks prognosis for lung cancer with non-omics data: African cohort
- Real-World Outcomes of Combination Anthracycline and Taxane Adjuvant Therapies in Early Triple-Negative Breast Cancer: A Moroccan Retrospective Analysis
- Combined impact of patients and disease characteristics on survival outcome in early hormone receptor negative patients across SBR grades.
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Real world results of locally advanced and metastatic lung cancer patients treated with platinum doublet chemotherapy in first line: Moroccan cohort
- 293P Evaluating chemotherapy side effects in Moroccan breast cancer patients and introducing an AI mobile health app for remote support: A comprehensive approach
- 378P First-line systemic treatment outcomes in a real-world advanced pancreatic cancer cohort
- Investigating the outcome of vascular emboli in patients with breast cancer.
- Lung cancer in middle and southern Morocco
- Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort
- 214P Development of a nomogram to predict the progression-free survival in lung cancer patients
- P-356 Oesophageal cancer standing in Morocco from diagnosis to treatments
- P-366 Development and validation of a predictive tool for oesophageal cancer patients: A Moroccan-based study
Publication venues
- Journal of Clinical Oncology × 3
- Annals of Oncology × 3
- ESMO Open × 2
- Journal of Thoracic Oncology × 2
- BMC Cancer × 2
- Frontiers in Oncology × 1
Publications per year
- 20262
- 20254
- 20245
- 20235
Collaborations
Partner institutions : Hôpital Militaire Avicenne · Université Ibn-Tofail · Université Mohammed VI des Sciences et de la Santé
Co-authors
- Hassan Abdelilah Tafenzi
- Rhizlane Belbaraka
- Ismail Essâdi
- Anas Baladi
- Youssef Ait Takniouine
- Ismail Essaadi
- Anass Baladi
- I. Essadi
- Edwin Kelly Haag
- Mohammed El Fadli
- R. Belbaraka
- K. Cissé
Bibliographic data from OpenAlex (open database).
Why choose DzCademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.